On February 13, AmCham Healthcare Committee met with Director General of the National Health Insurance Company, Mr. Dumitru Parfentiev, and his team.
The discussions focused on peculiarities of the current system for reimbursement of medicines from public funds, covering such aspects as content of the national treatment protocols, criteria for including drugs in the compensated list and relevant administrative procedures.
The parties have reinforced the need to continue collaboration on improving legislation in this area.
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
---|---|---|---|---|---|---|
Latest Advocacy on the Go